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The ordinary cutaneous manifestations of bromide eruptions
are well known. Numerous reports have appeared in the litera-
ture supporting various theories as to the development of cutane-
ous lesions due to bromides but practically no one has studied
the plasma bromide levels with relation to bromoderma.
Hanes and Yates (1) found approximately 0.9 per cent of the total admissions
to Duke Hospital had increased amounts of bromide in their plasma. They also
found that 28 per cent of 64 patients with blood serum bromides above 200 mgm.
had bromoderma. The percentage of patients with significantly elevated plasma
bromides is even higher among patients admitted to psychopathic hospitals.
Szadek (2) believed that the cutaneous eruption originated from an irritation
of the sebaceous glands.
Laudenheimer (3) and Von Wyss (4) thought that the ingestion of bromide led
to a gradual retention of the drug in the tissues and the replacement of the
chloride.
Engman and Mook (5) felt that the lesions were more apt to occur at the site
of previous inflammation and that trauma might play a part, thereby explaining
the predilection of a bromoderma for old seborrheic or acne areas.
Wile (6) stated that he was unable to demonstrate the drug in the content of
the lesions and he believed that it was not present unless there was an admixture
of blood serum.
Bloch and Tenchio (7) considered bromoderma to be an idiosyncratic phenome-
non of the skin and mucous membranes brought about by sensitization.
Barbital derivatives have to some extent supplanted bromides. Nevertheless
according to Hanes and Yates (1) the wide use of bromides today is shown by the
report of the American Association of Pharmacy of 1935 in which it was stated
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that the number of prescriptions calling for bromides is second oniy to aspirin.
Bromide prescriptions can be refilled and thus lead to extensive self-medication.
It is also probable that there are over two hundred patent medicines which
contain bromide available to the laity. These should be regarded quite seriously,
as bromide alleviates temporarily the symptoms which it produces.
Mild symptoms of bromide intoxication include dull morning headache, consti-
pation, indigestion, fatigue, irritability, sleeplessness, difficulty in concentration
and poor memory. If more bromide is taken, a psychosis may develop. Mild
toxic symptoms may be present with blood levels of 50 to 150 mgm. Wagner and
Bunbury (8) found serious psychopathic symptoms when the bromide concentra-
tion of the plasma exceeded 200 mgm. and they considered over 300 mgnl. to be
quite dangerous to life.
The common type of eruption induced by bromide is acneform. It usually
occurs on the face and upper portions of the trunk, a distribution like that ordi-
narily found in acne. The sudden onset of pustular acneform lesions should at
once arouse suspicion of bromoderrna, even more so if there is an absence of
comedones.
Another type frequently seen is proliferative and becomes granulomatous. It
occurs more often on the lower extremities and may simulate localized blastomy-
cosis; but no true iniliary abscesses can be found. Involution may require weeks
or months.
An erythema nodosum-like eruption may occur. In addition to the ordinary
types, macules, papules, tubercles, urticarial wheals and areas of dermatitis may
occur.
In the present studies the plasma bromide levels were deter-
mined in 16 patients with bromoderma. Most of these patients
were then treated by the administration of chlorides with rapid
disappearance of their lesions. In 4 patients the bromoderma
was then reproduced to find the relationship between the induced
bromoderma and the level at which it appeared. Bromides
were also given to a control group in an effort to produce bromo-
derma in normal persons. The records of another group with
mental symptoms of bromism were studied to find the levels in
bromide psychosis. The rate of storage and elimination of
bromide was determined by following its level in the plasma.
The Malamud (9) modification of the Rappleye's bromide method was em-
ployed to estimate the bromide content of the blood plasma.
Reagents are as follows: 20 per cent trichloracetie acid to precipitate protein;
0.5 per cent gold chloride solution (Merck's acid, yellow) in which gold combines
with the bromides to give a brown color; and normal saline diluting fluid.
Two cubic centimeters of clear plasma are placed in a test tube. To this are
added 4 cc. of normal salt solution and 2 cc. of the 20 per cent trichloracetic acid.
The tube is shaken well, allowed to stand a few minutes and centrifuged. The
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supernatant fluid is then filtered through a small (4 cm.) filter paper. To 5 cc.
of the filtrate add 1 cc. of the 0.5 per cent gold chloride solution and compare in a
standard colorimeter set at 10 mm. against a standard bromide solution. This
standard consists of a solution containing 100 mgm. of sodium bromide in 75 cc.
of normal saline and 25 cc. of 20 per cent trichloracetic acid. Use S cc. of the
standard solution and 1 cc. of 0.5 per cent gold chloride solution.
Calculations: . . X number of cubic centimeters of standard
colorimeter reading
used = milligrams of sodium bromide per hundred cubic centimeters.
The use of the modified Rappleye's bromide test provided a relatively simple
and universally applicable means of estimating the concentration of bromide in
the blood and spinal fluid.
The plasma bromides were determined in 16 patients with
bromoderma. Table 1 gives a resume of the pertinent facts in
this group. The bromide levels varied from 25 to 400 mgm.
with an average of 178 mgm. There was no direct correlation
between the level of plasma bromide and the presence of cutane-
ous lesions. Likewise, there was no critical level at which the
individual patient's eruption disappeared. The acneform erup-
tions occurred after bromide had been taken for a relatively
short time, that is, from one week to, in 1 patient, five months.
The granulomatous lesions took longer to develop and were all
accompanied by an acneform eruption. Those patients who
once had a bromide exanthem developed a bromoderma on
resumption and continuation of the intake of bromide.
We found that if supplemental salt is taken, small doses of
bromide can be given without always bringing forth an eruption.
Some lesions increased in extent even months after the bromides
had been discontinued. This is one of the reasons for the great
difficulties often encountered in trying to obtain a history of
ingestion of the drug. The bromodermas disappeared while
there was still a considerable amount (usually 40 mgm.) of
bromide in the blood. Age or sex did not influence the develop-
ment of the eruption, nor did it matter which bromide salt was
taken.
In an effort to produce bromoderma, 14 patients were given
bromides to find out if bromoderma could be produced in normal
individuals or reproduced in those who had had bromoderma.
To determine whether normal individuals would develop
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bromoderma 10 subjects were given bromides. The amount
given was sufficient to raise the plasma levels above 75 mgm.
with an average level of 216. Five of these subjects were between
fourteen and eighteen years of age but none had acne. One of
them had a greasy skin. None of these patients developed
bromoderma, but 1 had a marked exacerbation of an atopic
dermatitis and 2 others became temporarily disoriented. These
findings indicate that the normal individual does not develop
TABLE 1
Patients with bromoderma on admission
All patients with granulomatous lesions also had acneform lesions
LENGTH OP
BRO- TIME BRO-
PATIENT SEX AGE DURATION TYPE OF LESION HIDE FORM HIDES
LEVEL WERE
TAKEN
year8
1 F 18 1 wk. Acneform 25 Prescription 1 wk.
2 F 40 4 mos. Granulomatous 40 Prescription
3 F 36 2 wks. Acneform 50 Nervine 3 mos.
4 F 30 9 mos. Granulomatous 68 Bromoseltzer 6 yrs.5 M 37 1 wk. Acneform 75 Prescription 1 wk.6 M 1 mo. Granulomatous 80 Prescription
7 F 40 9 mos. Granulomatous 84 Prescription
8 F 24 Acneform 140 Nervine
9 F 35 5 wks. Granulomatous 174 Prescription
10 F 25 5 wks. Acneform 174 Prescription 5 mos.11 M 38 2 mos. Acneform 178 Bromoseltzer 2 mos.
12 F 31 1 wk. Erythema 184 Prescription 10 days13 M 38 3 wks. Granulomatous 188 Bromoseltzer 16 yrs.14 M 46 3 yrs. Granulomatous 274 Bromoseltzer 5—6 yrs.
15 F 25 3 wks. Acneform 296 Prescription 3 wks.16 M 40 4 wks. Acneform 345 Prescription 10 wks.
bromoderma even though the plasma bromide levels are much
higher than those individuals with spontaneous bromoderma.
Four patients, numbers 4, 7, 10 and 12 of Table 1 were treated
until their cutaneous lesions had healed and the bromide levels
of the blood were below 50 mgm. They were then given bromide
by mouth in a dose of 1 gram t.i.d. and their plasma bromide levels
were determined regularly. Bromide eruptions of the acneform
type developed in all. In 3 of them the level of development
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was lower than the entrance level with the spontaneous bromo-
derma; in 1 it was higher. Later 1 of these 4 developed a granulo-
matous lesion at a much lower level of plasma bromide than when
she had the acneform type. Chart 1 gives the bromide levels in
5 10 15 20 25
CHART 2. THE RISE OF THE PLASMA BROMIDE LEVEL IN A PATIENT GIVEN 3 GRAMS
OF BROMIDE SALT DAILY
one of these patients in whom bromoderma was reproduced.
The legend is self-explanatory. These results indicate that
bromoderma can be reproduced in almost all individuals who
have previously had bromide eruptions.
The findings in the two groups of cases indicate that for an in-
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CHART 1. BROMIDE LEVELS IN ONE OF THE PATIENTS IN WHOM BROMODERMA
WAS REPRODUCED
X. Level at entrance with bromide acne and granuloma.
A. Acne gone. Granuloma better.
B. No bromide eruption. Bromide given by mouth.
C. Reappearance of acne.
D. Bromide discontinued.
B. Acneform eruption clearing. Granuloma recurring.
F. Granulonia well developed.
0. Granuloma disappearing. Acne gone.
H. and K. All lesions gone.
DAY S
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dividual to develop bromoderma he must presumably have an idio8yn-
crasy to the bromide ion.
Thirteen patients with mental symptoms of acute bromism had
plasma bromide levels varying from 57 to 562 mgm. with an
average of 281 mgm. The bromide level of those patients who
developed mental symptoms was in general considerably higher
than those who developed cutaneous lesions. Only 1 patient
was seen who had both cutaneous and mental symptoms from
bromides. This is a much lower percentage of combined mental
and cutaneous bromism than Hanes and Yates found in their
study. The presence of bromoderma is therefore not a criterion
for the general diagnosis of bromism or bromide psychosis.
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CHART 3. THE LEVELS OF PLASMA CHLORIDE AND BROMIDE IN ONE PATIENT
Since bromide balance studies would have been extremely
difficult to do, it was thought that the retention of bromides
could be approximated by studying the plasma bromide levels
of individuals given bromides by mouth.
Thirteen patients on a normal hospital diet, containing ap-
proximately 7 grams of sodium chloride daily, were given bro-
mides. None of these had cardiorenal disease. Almost all of
these received 1 gram of a bromide salt three times daily and the
blood plasma bromides were estimated regularly. The elevation
of plasma bromides produced by the ingestion of 1 gram of sodium
bromide varied from 0.46 mgm. to 5.8 mgm. Chart 2 indicates
the rise of the bromide level in a typical patient given 3 grams of
bromide salt daily.
———PLASMA CHLQRDE
—PLASMA BROMIDE
0 I
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The chloride content of the body is maintained at a remarkably
constant level. When excess chloride is ingested, an excess is
excreted and vice versa. In 8 patients the plasma chlorides were
repeatedly determined at the same time as the plasma bromides.
When bromide is absorbed the level of bromide increases and that
of chloride decreases, indicating that the chloride has been re-
placed by bromide.
There was considerable variation in the curves of the 8 patients;
but the curve (chart 3) obtained on 1 patient represents the ideal
condition of the relation of the levels of chloride and bromide
keeping the total halogen level relatively constant.
TABLE 2
The decline of plasma bromides in milligrams per hundred cubic centimeters
per day
LEVEL OP PLASMA BRO-
MIDES IN MILLIGRAMS PER
HUNDRED CUBIC CENTI-
METERS
NORMAL DIET SALT BY MOUTH SALT INTRAVENOUSLY
300—
200—300
0—200
22
10
7.4
26
15
13
37
21
16
The levels of plasma bromides were followed in 40 patients to
estimate the effect of administration of sodium chloride on the
rate of elimination of the bromide. The estimations were made
on 22 patients on a normal hospital diet which contains approxi-
mately 7 grams of table salt per day, on 13 who were given in
addition 7 grams of table salt daily by mouth and on 5 who were
given saline solution intravenously—usually 200 cc. of 2 per cent
salt solution daily. The composite curves of these patients show
that the effects upon the bromide levels fall in the following order:
saline intravenously, added salt by mouth, and normal diet—the
last giving the least fall in bromide level. There was no rise in the
bromide levels after intravenous saline and there were no un-
toward results from the giving of this relatively large amount of
saline. Two controls with bromide levels of about 200 mgm.
were given respectively 5 per cent glucose intravenously and a
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mercurial diuretic. There was no acceleration in the decline of
the bromide levels over those on a normal hospital diet.
Table 2 shows the average decline per day of the three groups
of patients at the various levels of plasma bromide. The curves
in chart 4 are a graphic illustration of the figures in table 2. The
relative decline in the three groups is approximately the same.
All three show the greatest decline at the higher levels and pro-
gressive lessening of the decline as the levels fall.
CHART 4. TuE AVERAGE DECLINE OF THE PLASMA BROMIDES
LEVELS AS DETERMINED IN 40 PATIENTS
SUMMARY
The blood plasma bromide level was estimated in 16 patients
with bromoderma. After treatment with sodium chloride, bro-
mides were once more given to 4 of these patients and their
bromoderma was reproduced. A control group of patients were
given large amounts of bromide in an endeavor to induce bro-
moderma but this was uniformly unsuccessful. The rate of
storage of bromide in the plasma and its rate of excretion were
studied. It is concluded that there is no direct correlation be-
tween the blood plasma bromide level and the occurrence of
bromoderma. The value of giving sodium chloride to patients
DAYS
AT THE VARIOUS
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with bromism is clearly shown. The tendency of bromide to
replace chloride in the plasma or vice versa is confirmed.
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DISCUSSION
DR. THEODORE CORNBLEET, Chicago: It is of interest that whereas the blood
bromide level may increase almost unlimitedly, that of the sweat is relatively
quite fixed. After a certain rise of sweat bromide level, a plateau is reached which
is not influenced by further increases in the quantity of blood bromide.
Appreciable quantities of bromide are present in the blood normally.
The mechanism by which skin lesions are produced by bromides still requires
elucidation, I believe. The usual view at the present time is that they are the
result of an allergic phenomenon. With this view I disagree until more proof is
had. The production of lesions requires usually the presence of considerable
bromide in the blood, even when the individual is already sensitized. When
chlorides are administered, the lesions early improve rapidly, and then after a
short period of this, settle down to a slow rate of involution even though the
chloride continues to be exhibited. The lesions finally do clear, notwithstanding
the fact that bromides are still present as shown by examination of the sweat.
It is true that allergy is based somewhat on the presence of substances in quantity.
At the same time these quantities are exceedingly small, quite smaller than the
amounts of bromide still present in the sweat after healing of bromoderma lesions.
When an individual is allergic to, say, a coal tar product, he reacts to small
quantities of it and the lesions heal simultaneously with its excretion. The
substance is not present after involution of the offending agent. Some bromide
is still present, however, after involution of a bromide rash. This makes me feel
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that Bromoderma is not purely an allergic affair, but at least in part based on
some quantitative relationship. That is to say that it may be a toxicological
reaction in the ordinary sense. It is my feeling that the allergic phenomenon is
all too readily invoked to explain many biological reactions and that we are
neglecting too often the older toxicological explanation.
The amount of bromide in the cells as shown in the skin is directly proportional
to that present in the blood. That present in the urine is relatively fixed. It
has been shown that a fixed percentage of the blood bromide appears in the
urine. This brake on the acceleration of urinary excretion of bromide is due
to the reabsorption of large quantities back into the blood by the kidney tubules.
It would be of interest to see what the influence of chloride administration has
on the rate of bromide excretion through the skin. The exfoliating epidermis
can hold huge quantities of bromide. Since the excretion of bromide through
the kidney due to the administration of chloride is somewhat limited, it is possi..
ble that some other disposition may be made of this bromide. The large tracts
of connective tissue and its spaces are known to be important reservoirs for
water and salts. Bromides could be temporarily consigned there somewhat in
the fashion that lead may be deposited in the bones.
Dr. Kimberly's paper suggests many other topics for discussion; it was most
interesting, valuable because of its large amount of data, which showed pains-
taking effort.
Da. J. LAMAR CALLAWAY, Durham, N. C.: Recently I had the occasion to re-
view the records that Dr. Kimberly spoke of. Blood bromides in all those cases
were studied very carefully and some patients were found to have bromides as
high as 428 mgm. per cent in the blood with a chloride replacement of 43 per cent.
In all of these cases there was absolutely no relation between the amount of blood
bromides and the presence or absence of skin lesions. About 25 per cent of
patients with blood bromides above 200 mgm. per cent had some skin manifesta-
tions, but only a few of these were definite bromodermas.
I agree with Dr. Cornbleet in the matter of chloride replacement of the
bromides. We came to the conclusion as he did that the excretion of bromides
did not depend directly on the amount of chlorides given but rather that a certain
amount is excreted daily. Accordingly we have given up the use of saline
intravenously and are giving sodium chloride by mouth in from 10 to 12 grams
daily or in the form of bouillon. It appears that there is a fixed tissue sensitivity
in the skin which results in the bromoderma rather than being due to the amount
of blood bromides present. The skin bromides content should be investigated
fully in bromodermas.
Da. S. M. PECK, New York: I wish to express my appreciation to Dr. Kimberly
for this paper. I have stated at several meetings that I was convinced that
bromoderma was caused by a real hypersensitivity rather than a toxic reaction.
It is for this reason that I disagree with Dr. Cornbleet. It is obvious that within
limits, the drug eruption bore no relationship, if it is based on a hypersensitivity,
to the quantity of blood bromides. This is quite evident by the prompt reelicita-
tion of the eruption by a small quantity of the drug once the hypersensitivity has
developed. Such clinical experiments seem to me to prove that we were dealing
with an idiosyncrasy.
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Several years ago I had the opportunity to study a group of patients who had
been given bromides for a number of years as part of a treatment for duodenal
ulcer. It was striking to note that the incidence of bromide eruptions was great-
est in those patients having a tendency to acne and seborrhea. It might be of
importance to correlate such observations with the development of bromide and
iodine eruptions.
S. ROTHMAN, Chicago: By these careful experiments two facts have been
confirmed: 1. the mutual interchangeability of Cl and Br in the skin as first shown
by Ellinger and Kotake; 2. the allergic mechanism of bromoderma as shown by
Bloch and Tenchio. The development and further course of bromoderma has no
relations to the bromide level of the blood.
DR. A. B. LOVEMAN, Louisville, Ky.: I quite agree with Dr. Peck and disagree
with Dr. Cornbleet. I feel there is much evidence from Dr. Kimberly's work to
show that bromoderma is definitely allergic. First, there was very little relation
between blood plasma bromides and the appearance of the eruption. Second,
he was unable to produce bromoderma with apparently tremendous doses of
bromides in normal individuals. I think there are other practical aspects of this
paper. We as dermatologists realize that bromodermas and iodermas flare up
quite frequently and exacerbate after the drug has been discontinued. Accord-
ing to the chart shown, some twenty days after the bromides were stopped,
granulomatous lesions and even pustules developed.
I was interested in hearing Dr. Callaway say that he no longer gives saline
intravenously in bromoderma.
We calculated recently how much sodium chloride patients were getting
intravenously, and it was relatively small when compared to the amount of saline
one could give with ease by mouth. I should like to ask Dr. Kimberly if he does
not feel that intravenous therapy in most cases is unnecessary. I think Dr.
Kimberly is to be congratulated for presenting such an excellent paper.
DR. RICHARD S. WEISS, Saint Louis: We are greatly interested in Dr. Kim-
berly's work. The studies which we have made in the last few years on blood
bromide levels in cases of bromoderma have shown a bromide content of some-
where between 10 to 30 mgm. per cent.
In considering the pathogenesis of bromoderma, I think that we should recall
the pioneer work of Engman Sr. which was done some 25 years ago. Dr. Engman
clearly showed that eruptions due to the halogen drugs as well as other drugs
could be precipitated, in fact were often precipitated by trauma. The trauma
could either be mechanical or could be the trauma due to disease such as acne or
seborrheic manifestations. All of you will recall that most of the granulomatous
nodules are in regions of the body subject to trauma and the acneform lesions
usually occur in individuals either with acne or who have previously had acne.
When we consider the plasma bromine level in relation to the appearance of
bromide eruptions and taking into consideration the element of trauma we are
led to the thought that perhaps the bromine in the fixed tissue cells rather than
the bromine in the plasma is the ion which causes the lesions.
I have no quarrel with the allergists if they want to call it allergic. In the
present state of our knowledge it seems to me better to call it idiosyncracy. But
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when we consider the bromide ions that are fixed in the tissues and further, the
fact that trauma changing the chemical surroundings may liberate these ions in
situ, we can then conceive of the mechanism which produces the lesions.
Da. L. W. Kiiunaatv, Iowa: Studies were begun knowing that there seemed to
be some parallel between blood plasma bromide levels and the appearance of
psychosis. I really thought that I would find that there was some direct correla-
tion between the appearance of cutaneous lesions and the level of the plasma
bromides. I do not want to imply that a certain amount of chloride when ad-
ministered would cause the same amount of bromide to be displaced, that is, I
do not believe there is an absolute exchange between bromine and chlorine.
As to the question of giving salt to these patients, I do not believe it is neces-
sary to give intravenous saline. All our work was done in the hospital, and when
the saline was given intravenously we were more certain of the amount of saline
given than when it was given by mouth.
It has recently come to my attention that Toenhart, 0 has found that he lowers
plasma bromide more rapidly by aspirating gastric contents shortly after the
intravenous administration of saline. I plan to do further work along these lines.
